Value-Driven Pharma

The 2009 Value-Driven Pharma Conference is the first and only conference focusing specifically on the paradigm shift in payors’ criteria on placing value on drugs. This program was created directly through insight and feedback from professionals in both pharma and payor perspectives relating to value-driven drug benefit design and the changes the pharmaceutical industry is undergoing as a result.

With this, we have been able to develop a program packed with discussions on how to productively respond to the changing economics of drug “value” metrics to remain competitive. Extend your company’s reach – attending Value Driven Pharma will give you access to the industry’s motivators and influencers. The distinguished speaker faculty features:

• Tom Daschle, Former Senate Majority And Minority Leader, UNITED STATES SENATE
• Allan Korn, MD, FACP, Chief Medical Officer and Senior Vice President for Clinical Affairs, BLUE CROSS BLUE SHIELD ASSOCIATION (BCBSA)
• Edmund Pezalla, MD, MPH, National Medical Director For Pharmacy, AETNA PHARMACY MANAGEMENT
• Luis T. Gutierrez, Jr., President, Commercialization Services, COVANCE INC
• Cynthia J. Pigg, Executive Director, ACADEMY OF MANAGED CARE PHARMACY
• Art Small, MD, Director, Value Based Healthcare, GENENTECH INC
• Lida Etemad, PharmD, MS, Senior Director, PDL Development, UnitedHealth Pharmaceutical Solutions, UNITED HEALTHGROUP

If you are interested in joining a group of professionals focusing on Value Driven Pharma, follow us on Twitter or join our LinkedIn group.

Share this article with your social network, just click below to share now!

Share |